id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0033-0067,FDA,FDA-2006-P-0033,"Petition Response Letter from FDA CDER to Anthony L. Young on behalf of Botanical Laboratories, Inc.",Other,Letter(s),2020-05-26T04:00:00Z,2020,5,2020-05-26T04:00:00Z,,2020-05-26T18:17:10Z,,0,0,09000064846aeba2
FDA-2006-P-0033-0066,FDA,FDA-2006-P-0033,Petition Response Letter from FDA CDER to Anthony L. Young on behalf of Pharmavite,Other,Letter(s),2020-05-26T04:00:00Z,2020,5,2020-05-26T04:00:00Z,,2020-05-26T18:16:55Z,,0,0,09000064846aeb9d
FDA-2006-P-0033-0068,FDA,FDA-2006-P-0033,Petition Response Letter from FDA CDER to Ms. Guggenheim on behalf of Cargill,Other,Letter(s),2020-05-26T04:00:00Z,2020,5,2020-05-26T04:00:00Z,,2020-05-26T18:22:20Z,,0,0,09000064846af529